Lexaria Bioscience Corp LEXX

Buzz on the Bullboards: TSX hits new high amid holiday optimism and sector disparities

[PressRelease]

(TheNewswire)World’s First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 MoleculesKelowna, British Columbia – November 14, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has...read article.

[Jonathon Brown]

This past week, the TSX reached a new intraday high, reflecting a buoyant market sentiment as investors gear up for the holiday season. read article.

[PressRelease]

(TheNewswire)DehydraTECH clinical test article manufacturing has been completedKelowna, British Columbia – TheNewswire - November 13, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has received lead...read article.

[PressRelease]

(TheNewswire)DehydraTECH™ for GLP-1 being optimized for global pharmaceutical useKelowna, British Columbia – TheNewswire - November 7, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms provides the following glucagon...read article.

[PressRelease]

(TheNewswire)DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groupsKelowna, British Columbia – October 24, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery...read article.

[PressRelease]

(TheNewswire)DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groupsAccelerated rates of weight loss were experienced during the final 4 weeks of the study in all DehydraTECH groupsKelowna, British Columbia – October 22, 2024 – TheNewswire...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 16, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced that it has closed its previously announced registered direct offering priced at...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 15, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of 1,633,987 shares of...read article.

[shawk]

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing (accesswire.com)

[shawk]

Game-Changing Oral GLP-1 Coming Soon! (youtube.com) About the 8 minute mark.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – October 1, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective...read article.

[PressRelease]

(TheNewswire)First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKelowna, British Columbia – September 27, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms...read article.

[whytestocks]

Breaking News: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal StudyLexaria, a global innovator in drug

[PressRelease]

(TheNewswire)Kelowna, British Columbia – September 5, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to provide this letter from outgoing Chief Executive Officer (“CEO”) Chris Bunka as a...read article.

[PressRelease]

(TheNewswire)Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor Kelowna, British Columbia – September 5, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – TheNewswire - September 3, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that it has entered into a Material Transfer Agreement with a pharmaceutical company...read article.